Allergies & Asthma

Traveling can bring excitement, anxiety, and stress, whether you’re driving a short distance for the day or flying across the country for an extended business trip or vacation. Add food allergies to the mix and traveling can be overwhelming. Researching dining and flight options, communicating your allergies with others, remembering to pack important allergy-friendly items,
0 Comments
Traffic-related air pollution was responsible for nearly 2 million new asthma cases in children across the globe in 2019, according to a new study. Of the 1.85 million new pediatric asthma cases that were attributed to nitrogen dioxide (NO2), two-thirds occurred in urban areas, reported Susan Anenberg, PhD, of George Washington University in Washington, D.C.,
0 Comments
When you hear “environmental allergies,” trees, grasses, and weeds might be the first allergens that come to mind. Just when you breathe a sigh of relief from waning outdoor allergens, prepare for sneaky indoor environmental allergens. Mold and dust mites trigger allergies throughout the year. But, as winter rolls around and you begin spending more
0 Comments
The FDA approved the only biologic for severe asthma without any phenotype or biomarker limitations, manufacturers AstraZeneca and Amgen announced Friday. The first-in-class biologic tezepelumab-ekko (Tezspire) is indicated as an add-on maintenance treatment for patients ages 12 and older with severe asthma. It is not intended for acute bronchospasm or status asthmaticus. As a first-in-class
0 Comments
Interventions to de-escalate use of inhaled corticosteroids (ICS) in patients with chronic obstructive pulmonary disease (COPD) are necessary and beneficial, researchers said during the federal posters session at the American Society of Health-System Pharmacists (ASHP) Midyear virtual meeting. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines recommend long-acting beta2-agonists (LABA) and long-acting muscarinic
0 Comments
NEW ORLEANS — Everyone who received their second dose of the Moderna or Pfizer mRNA vaccine against COVID-19 at military facilities after experiencing allergic reactions to the first did just fine without any pretreatment, a physician reported here. These individuals were observed closely, of course, and some underwent allergy testing beforehand to ascertain whether they
0 Comments
NEW ORLEANS — Safety of a dermal patch for helping peanut-allergic children tolerate the ubiquitous legume improved over time in a 3-year, open-label study, a researcher reported here. Although adverse effects (AEs) from the product were common in the first year, they diminished markedly in subsequent years, said Terri Brown-Whitehorn, MD, of Children’s Hospital of
0 Comments
NEW ORLEANS — Although 2017 government-endorsed guidelines called for introducing peanuts in infancy in order to minimize risk of future allergy, few parents are getting that message from their pediatricians, survey results indicate. Among 3,062 parents of young children participating in the survey earlier this year, only 58% recalled any discussion with their child’s pediatrician
0 Comments
Two monoclonal antibodies directed toward different interleukin (IL) targets produced wildly different results in randomized phase II trials involving asthma. On the plus side, an IL-33 inhibitor called itepekimab appeared to help patients keep their asthma under control better than placebo, reported Michael Wechsler, MD, of National Jewish Health in Denver, and colleagues. While on
0 Comments
If you suffer from allergies, you likely feel the everyday impacts allergies can cause. We have good news — there is a safe, cost-effective, and convenient option available that might help you enjoy everyday activities and live your ideal lifestyle without worrying about allergies slowing you down. Sublingual immunotherapy (SLIT), commonly known as allergy drops,
0 Comments
Exacerbations were eliminated in about one-third of adult asthma patients treated prophylactically with the macrolide azithromycin, a researcher reported. In the real-world study presented at CHEST 2021, the American College of Chest Physicians annual meeting held online, Hanan Ajay, a fifth-year medical student at the University of Liverpool in England said that of the 34
0 Comments
An oral abstract session at CHEST 2021 on Wednesday devoted to chronic obstructive pulmonary disease (COPD) offered a prime example of how a question-and-answer segment can be far more interesting than the actual presentations. One of the abstracts was a run-of-the-mill secondary analysis of years-old clinical trial data, while another examined claims data related to
0 Comments
Children with uncontrolled, moderate-to-severe asthma had better long-term lung function when they were treated with dupilumab (Dupixent), a randomized study showed. In the year-long trial, add-on dupilumab given to children ages 6-11 improved forced expiratory volume in 1 second (FEV1) by a pre-bronchodilator average of 0.06 liters at week 2 versus placebo (P=0.025), and by
0 Comments
It’s probably no surprise that the most significant respiratory disease epidemic in 100 years is the number one subject at this year’s CHEST meeting. But healthcare professionals with interests in more traditional topics shouldn’t feel cheated, a review of abstracts and scheduled sessions indicates. Of the nearly 2,100 abstracts published ahead of the meeting —
0 Comments
Are you one of the over 50 million Americans who experiences allergies each year? Signs and symptoms of an allergic reaction can range from a bothersome stuffy/runny nose, sneezing, and itchy/watery eyes to a rash, difficulty swallowing and anaphylaxis. What actually happens during an allergic reaction? Is there a way to treat the cause? We’ll
0 Comments
In today’s world, there are endless options for the same or similar services – even when it comes to healthcare. We understand that it can be difficult to decide which allergy skin test option is best for you, or to know who or what to trust when it comes to diagnosing your allergies. Dr. Mary
0 Comments
Diagnostic accuracy of confocal laser endomicroscopy (CLE) was too low to identify wheat sensitivities in non-celiac irritable bowel syndrome (IBS) patients, according to a prospective multicenter study. The method accurately detected wheat sensitivity in only about half of the individuals who responded to a gluten-free diet at 2 months (51.4% sensitivity, 97.5% CI 38.7-63.9%), reported
0 Comments